nodes	percent_of_prediction	percent_of_DWPC	metapath
Levothyroxine—ALB—lung cancer	0.127	0.512	CbGaD
Levothyroxine—ABCB1—lung cancer	0.121	0.488	CbGaD
Levothyroxine—SLCO4C1—Methotrexate—lung cancer	0.0579	0.113	CbGbCtD
Levothyroxine—SLCO1B3—Paclitaxel—lung cancer	0.0435	0.0851	CbGbCtD
Levothyroxine—SLCO1C1—Methotrexate—lung cancer	0.0406	0.0796	CbGbCtD
Levothyroxine—SLCO1B3—Docetaxel—lung cancer	0.0314	0.0615	CbGbCtD
Levothyroxine—ALB—Gefitinib—lung cancer	0.0256	0.0502	CbGbCtD
Levothyroxine—SLCO1B1—Irinotecan—lung cancer	0.025	0.0489	CbGbCtD
Levothyroxine—SLCO1B3—Methotrexate—lung cancer	0.0227	0.0444	CbGbCtD
Levothyroxine—ALB—Erlotinib—lung cancer	0.0151	0.0297	CbGbCtD
Levothyroxine—ABCB1—Topotecan—lung cancer	0.0147	0.0287	CbGbCtD
Levothyroxine—SLCO1A2—Methotrexate—lung cancer	0.014	0.0274	CbGbCtD
Levothyroxine—ALB—Irinotecan—lung cancer	0.0137	0.0268	CbGbCtD
Levothyroxine—ABCB1—Gefitinib—lung cancer	0.0134	0.0262	CbGbCtD
Levothyroxine—SLCO1B1—Methotrexate—lung cancer	0.0132	0.0259	CbGbCtD
Levothyroxine—CYP2C8—Erlotinib—lung cancer	0.0117	0.0229	CbGbCtD
Levothyroxine—CYP2C8—Paclitaxel—lung cancer	0.0107	0.021	CbGbCtD
Levothyroxine—ABCB1—Vinorelbine—lung cancer	0.0103	0.0202	CbGbCtD
Levothyroxine—CYP3A4—Topotecan—lung cancer	0.00878	0.0172	CbGbCtD
Levothyroxine—CYP2C8—Etoposide—lung cancer	0.00847	0.0166	CbGbCtD
Levothyroxine—ABCB1—Crizotinib—lung cancer	0.00821	0.0161	CbGbCtD
Levothyroxine—CYP3A4—Gefitinib—lung cancer	0.00803	0.0157	CbGbCtD
Levothyroxine—ABCB1—Gemcitabine—lung cancer	0.00803	0.0157	CbGbCtD
Levothyroxine—ABCB1—Erlotinib—lung cancer	0.00792	0.0155	CbGbCtD
Levothyroxine—CYP3A4—Teniposide—lung cancer	0.00779	0.0152	CbGbCtD
Levothyroxine—ABCB1—Paclitaxel—lung cancer	0.00725	0.0142	CbGbCtD
Levothyroxine—ALB—Methotrexate—lung cancer	0.00724	0.0142	CbGbCtD
Levothyroxine—ABCB1—Irinotecan—lung cancer	0.00715	0.014	CbGbCtD
Levothyroxine—ABCB1—Vinblastine—lung cancer	0.00636	0.0125	CbGbCtD
Levothyroxine—CYP3A4—Vinorelbine—lung cancer	0.00618	0.0121	CbGbCtD
Levothyroxine—ABCB1—Cisplatin—lung cancer	0.00583	0.0114	CbGbCtD
Levothyroxine—ABCB1—Etoposide—lung cancer	0.00573	0.0112	CbGbCtD
Levothyroxine—ABCB1—Docetaxel—lung cancer	0.00524	0.0103	CbGbCtD
Levothyroxine—CYP3A4—Crizotinib—lung cancer	0.00492	0.00964	CbGbCtD
Levothyroxine—CYP3A4—Erlotinib—lung cancer	0.00475	0.0093	CbGbCtD
Levothyroxine—CYP3A4—Paclitaxel—lung cancer	0.00435	0.00851	CbGbCtD
Levothyroxine—CYP3A4—Irinotecan—lung cancer	0.00429	0.00839	CbGbCtD
Levothyroxine—ABCB1—Doxorubicin—lung cancer	0.00391	0.00765	CbGbCtD
Levothyroxine—CYP3A4—Vinblastine—lung cancer	0.00381	0.00746	CbGbCtD
Levothyroxine—ABCB1—Methotrexate—lung cancer	0.00379	0.00741	CbGbCtD
Levothyroxine—CYP3A4—Etoposide—lung cancer	0.00343	0.00672	CbGbCtD
Levothyroxine—CYP3A4—Docetaxel—lung cancer	0.00314	0.00615	CbGbCtD
Levothyroxine—THRB—mammary gland—lung cancer	0.00279	0.0671	CbGeAlD
Levothyroxine—CYP3A4—Doxorubicin—lung cancer	0.00234	0.00459	CbGbCtD
Levothyroxine—SLC7A5—mammary gland—lung cancer	0.00213	0.0512	CbGeAlD
Levothyroxine—SLCO4A1—mammary gland—lung cancer	0.00186	0.0447	CbGeAlD
Levothyroxine—SERPINA7—bone marrow—lung cancer	0.00176	0.0424	CbGeAlD
Levothyroxine—SLCO1B1—mammary gland—lung cancer	0.00164	0.0393	CbGeAlD
Levothyroxine—SLCO4C1—trachea—lung cancer	0.00143	0.0345	CbGeAlD
Levothyroxine—SLC7A5—respiratory system—lung cancer	0.00142	0.0341	CbGeAlD
Levothyroxine—TTR—respiratory system—lung cancer	0.00138	0.0332	CbGeAlD
Levothyroxine—ALB—mammary gland—lung cancer	0.00132	0.0318	CbGeAlD
Levothyroxine—SLC16A2—trachea—lung cancer	0.00124	0.0299	CbGeAlD
Levothyroxine—SLC7A5—epithelium—lung cancer	0.00119	0.0285	CbGeAlD
Levothyroxine—SLC16A2—cardiac atrium—lung cancer	0.00117	0.0281	CbGeAlD
Levothyroxine—SLC7A5—bronchus—lung cancer	0.00117	0.0281	CbGeAlD
Levothyroxine—SLCO4C1—bone marrow—lung cancer	0.00114	0.0273	CbGeAlD
Levothyroxine—SLC7A5—trachea—lung cancer	0.00105	0.0252	CbGeAlD
Levothyroxine—SLCO4C1—lung—lung cancer	0.00103	0.0248	CbGeAlD
Levothyroxine—SLCO4A1—bronchus—lung cancer	0.00102	0.0245	CbGeAlD
Levothyroxine—SLCO1B3—lung—lung cancer	0.001	0.0241	CbGeAlD
Levothyroxine—THRA—lung—lung cancer	0.000987	0.0237	CbGeAlD
Levothyroxine—THRB—lung—lung cancer	0.000987	0.0237	CbGeAlD
Levothyroxine—SLC7A5—cardiac atrium—lung cancer	0.000984	0.0237	CbGeAlD
Levothyroxine—CYP2C8—mammary gland—lung cancer	0.00093	0.0224	CbGeAlD
Levothyroxine—SLCO4A1—trachea—lung cancer	0.000915	0.022	CbGeAlD
Levothyroxine—SLC16A2—lung—lung cancer	0.000894	0.0215	CbGeAlD
Levothyroxine—SLCO4A1—cardiac atrium—lung cancer	0.00086	0.0207	CbGeAlD
Levothyroxine—SLC7A5—bone marrow—lung cancer	0.000831	0.02	CbGeAlD
Levothyroxine—TTR—bone marrow—lung cancer	0.00081	0.0195	CbGeAlD
Levothyroxine—SLC7A5—lung—lung cancer	0.000753	0.0181	CbGeAlD
Levothyroxine—TTR—lung—lung cancer	0.000733	0.0177	CbGeAlD
Levothyroxine—THRB—lymph node—lung cancer	0.000675	0.0162	CbGeAlD
Levothyroxine—THRA—lymph node—lung cancer	0.000675	0.0162	CbGeAlD
Levothyroxine—SLCO4A1—lung—lung cancer	0.000658	0.0158	CbGeAlD
Levothyroxine—SLC16A2—lymph node—lung cancer	0.000611	0.0147	CbGeAlD
Levothyroxine—SLCO1C1—lymph node—lung cancer	0.000561	0.0135	CbGeAlD
Levothyroxine—SLC7A5—lymph node—lung cancer	0.000515	0.0124	CbGeAlD
Levothyroxine—SLCO1A2—lung—lung cancer	0.000471	0.0113	CbGeAlD
Levothyroxine—SLCO4A1—lymph node—lung cancer	0.00045	0.0108	CbGeAlD
Levothyroxine—Liotrix—ALB—lung cancer	0.000355	0.296	CrCbGaD
Levothyroxine—Liotrix—ABCB1—lung cancer	0.000338	0.282	CrCbGaD
Levothyroxine—ALB—lymph node—lung cancer	0.00032	0.0077	CbGeAlD
Levothyroxine—ABCB1—respiratory system—lung cancer	0.000297	0.00715	CbGeAlD
Levothyroxine—Liothyronine—ALB—lung cancer	0.000259	0.216	CrCbGaD
Levothyroxine—ABCB1—epithelium—lung cancer	0.000248	0.00597	CbGeAlD
Levothyroxine—Liothyronine—ABCB1—lung cancer	0.000247	0.206	CrCbGaD
Levothyroxine—Tachycardia—Vinorelbine—lung cancer	0.000225	0.00229	CcSEcCtD
Levothyroxine—Feeling abnormal—Topotecan—lung cancer	0.000222	0.00226	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Topotecan—lung cancer	0.00022	0.00224	CcSEcCtD
Levothyroxine—ABCB1—trachea—lung cancer	0.00022	0.00528	CbGeAlD
Levothyroxine—Abdominal pain—Vinblastine—lung cancer	0.000219	0.00223	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Erlotinib—lung cancer	0.000218	0.00222	CcSEcCtD
Levothyroxine—Arrhythmia—Cisplatin—lung cancer	0.000217	0.00221	CcSEcCtD
Levothyroxine—Nausea—Teniposide—lung cancer	0.000216	0.0022	CcSEcCtD
Levothyroxine—Alopecia—Cisplatin—lung cancer	0.000215	0.00219	CcSEcCtD
Levothyroxine—Urticaria—Topotecan—lung cancer	0.000214	0.00218	CcSEcCtD
Levothyroxine—Abdominal pain—Topotecan—lung cancer	0.000213	0.00217	CcSEcCtD
Levothyroxine—Body temperature increased—Topotecan—lung cancer	0.000213	0.00217	CcSEcCtD
Levothyroxine—Abdominal pain—Erlotinib—lung cancer	0.000211	0.00215	CcSEcCtD
Levothyroxine—Body temperature increased—Erlotinib—lung cancer	0.000211	0.00215	CcSEcCtD
Levothyroxine—Coma—Doxorubicin—lung cancer	0.00021	0.00214	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Vinorelbine—lung cancer	0.00021	0.00214	CcSEcCtD
Levothyroxine—Weight decreased—Docetaxel—lung cancer	0.000209	0.00213	CcSEcCtD
Levothyroxine—Flushing—Etoposide—lung cancer	0.000207	0.0021	CcSEcCtD
Levothyroxine—Dyspnoea—Vinorelbine—lung cancer	0.000206	0.00209	CcSEcCtD
Levothyroxine—Acute coronary syndrome—Docetaxel—lung cancer	0.000203	0.00207	CcSEcCtD
Levothyroxine—Flushing—Paclitaxel—lung cancer	0.000203	0.00206	CcSEcCtD
Levothyroxine—Myocardial infarction—Docetaxel—lung cancer	0.000202	0.00206	CcSEcCtD
Levothyroxine—Asthenia—Vinblastine—lung cancer	0.000199	0.00203	CcSEcCtD
Levothyroxine—Fatigue—Vinorelbine—lung cancer	0.000199	0.00202	CcSEcCtD
Levothyroxine—Tremor—Cisplatin—lung cancer	0.000198	0.00202	CcSEcCtD
Levothyroxine—Alopecia—Etoposide—lung cancer	0.000197	0.002	CcSEcCtD
Levothyroxine—Arrhythmia—Paclitaxel—lung cancer	0.000195	0.00198	CcSEcCtD
Levothyroxine—Asthenia—Topotecan—lung cancer	0.000193	0.00197	CcSEcCtD
Levothyroxine—Arthralgia—Gemcitabine—lung cancer	0.000193	0.00197	CcSEcCtD
Levothyroxine—Alopecia—Paclitaxel—lung cancer	0.000193	0.00196	CcSEcCtD
Levothyroxine—Confusional state—Irinotecan—lung cancer	0.000192	0.00195	CcSEcCtD
Levothyroxine—Asthenia—Erlotinib—lung cancer	0.000191	0.00195	CcSEcCtD
Levothyroxine—Pruritus—Topotecan—lung cancer	0.000191	0.00194	CcSEcCtD
Levothyroxine—Feeling abnormal—Vinorelbine—lung cancer	0.00019	0.00193	CcSEcCtD
Levothyroxine—Diarrhoea—Vinblastine—lung cancer	0.00019	0.00193	CcSEcCtD
Levothyroxine—Pruritus—Erlotinib—lung cancer	0.000189	0.00192	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Vinorelbine—lung cancer	0.000189	0.00192	CcSEcCtD
Levothyroxine—Shock—Irinotecan—lung cancer	0.000187	0.0019	CcSEcCtD
Levothyroxine—Tension—Paclitaxel—lung cancer	0.000186	0.0019	CcSEcCtD
Levothyroxine—Nervousness—Paclitaxel—lung cancer	0.000185	0.00188	CcSEcCtD
Levothyroxine—Diarrhoea—Topotecan—lung cancer	0.000184	0.00188	CcSEcCtD
Levothyroxine—Cardiac failure congestive—Doxorubicin—lung cancer	0.000184	0.00187	CcSEcCtD
Levothyroxine—Irritability—Methotrexate—lung cancer	0.000184	0.00187	CcSEcCtD
Levothyroxine—Hyperhidrosis—Irinotecan—lung cancer	0.000184	0.00187	CcSEcCtD
Levothyroxine—Convulsion—Cisplatin—lung cancer	0.000183	0.00187	CcSEcCtD
Levothyroxine—Urticaria—Vinorelbine—lung cancer	0.000183	0.00186	CcSEcCtD
Levothyroxine—Mood swings—Methotrexate—lung cancer	0.000183	0.00186	CcSEcCtD
Levothyroxine—Diarrhoea—Erlotinib—lung cancer	0.000182	0.00186	CcSEcCtD
Levothyroxine—Abdominal pain—Vinorelbine—lung cancer	0.000182	0.00186	CcSEcCtD
Levothyroxine—Body temperature increased—Vinorelbine—lung cancer	0.000182	0.00186	CcSEcCtD
Levothyroxine—Anxiety—Cisplatin—lung cancer	0.000179	0.00183	CcSEcCtD
Levothyroxine—Hyperhidrosis—Gemcitabine—lung cancer	0.000179	0.00182	CcSEcCtD
Levothyroxine—Tremor—Paclitaxel—lung cancer	0.000178	0.00181	CcSEcCtD
Levothyroxine—Increased appetite—Doxorubicin—lung cancer	0.000178	0.00181	CcSEcCtD
Levothyroxine—Vomiting—Vinblastine—lung cancer	0.000176	0.0018	CcSEcCtD
Levothyroxine—Agitation—Paclitaxel—lung cancer	0.000175	0.00178	CcSEcCtD
Levothyroxine—ABCB1—bone marrow—lung cancer	0.000174	0.00419	CbGeAlD
Levothyroxine—Headache—Vinblastine—lung cancer	0.000174	0.00177	CcSEcCtD
Levothyroxine—Angioedema—Paclitaxel—lung cancer	0.000174	0.00177	CcSEcCtD
Levothyroxine—Insomnia—Irinotecan—lung cancer	0.000172	0.00175	CcSEcCtD
Levothyroxine—Flushing—Docetaxel—lung cancer	0.000172	0.00175	CcSEcCtD
Levothyroxine—Vomiting—Topotecan—lung cancer	0.000171	0.00174	CcSEcCtD
Levothyroxine—Cardiac failure—Doxorubicin—lung cancer	0.000171	0.00174	CcSEcCtD
Levothyroxine—Hypoglycaemia—Doxorubicin—lung cancer	0.000171	0.00174	CcSEcCtD
Levothyroxine—Rash—Topotecan—lung cancer	0.00017	0.00173	CcSEcCtD
Levothyroxine—Dermatitis—Topotecan—lung cancer	0.00017	0.00173	CcSEcCtD
Levothyroxine—Vomiting—Erlotinib—lung cancer	0.00017	0.00173	CcSEcCtD
Levothyroxine—Dyspnoea—Irinotecan—lung cancer	0.000169	0.00173	CcSEcCtD
Levothyroxine—Headache—Topotecan—lung cancer	0.000169	0.00172	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000169	0.00172	CcSEcCtD
Levothyroxine—Tachycardia—Cisplatin—lung cancer	0.000168	0.00172	CcSEcCtD
Levothyroxine—Rash—Erlotinib—lung cancer	0.000168	0.00171	CcSEcCtD
Levothyroxine—Dermatitis—Erlotinib—lung cancer	0.000168	0.00171	CcSEcCtD
Levothyroxine—Palpitations—Paclitaxel—lung cancer	0.000168	0.00171	CcSEcCtD
Levothyroxine—Convulsion—Etoposide—lung cancer	0.000168	0.00171	CcSEcCtD
Levothyroxine—Insomnia—Gemcitabine—lung cancer	0.000168	0.00171	CcSEcCtD
Levothyroxine—Headache—Erlotinib—lung cancer	0.000167	0.0017	CcSEcCtD
Levothyroxine—Hyperhidrosis—Cisplatin—lung cancer	0.000167	0.0017	CcSEcCtD
Levothyroxine—Asthenia—Vinorelbine—lung cancer	0.000165	0.00168	CcSEcCtD
Levothyroxine—Arrhythmia—Docetaxel—lung cancer	0.000165	0.00168	CcSEcCtD
Levothyroxine—Dyspnoea—Gemcitabine—lung cancer	0.000165	0.00168	CcSEcCtD
Levothyroxine—Nausea—Vinblastine—lung cancer	0.000165	0.00168	CcSEcCtD
Levothyroxine—Convulsion—Paclitaxel—lung cancer	0.000165	0.00168	CcSEcCtD
Levothyroxine—Affect lability—Doxorubicin—lung cancer	0.000164	0.00167	CcSEcCtD
Levothyroxine—Fatigue—Irinotecan—lung cancer	0.000164	0.00167	CcSEcCtD
Levothyroxine—Alopecia—Docetaxel—lung cancer	0.000163	0.00166	CcSEcCtD
Levothyroxine—Pruritus—Vinorelbine—lung cancer	0.000163	0.00166	CcSEcCtD
Levothyroxine—Arthralgia—Paclitaxel—lung cancer	0.000162	0.00165	CcSEcCtD
Levothyroxine—Anxiety—Paclitaxel—lung cancer	0.000161	0.00164	CcSEcCtD
Levothyroxine—Nausea—Topotecan—lung cancer	0.00016	0.00163	CcSEcCtD
Levothyroxine—Fatigue—Gemcitabine—lung cancer	0.00016	0.00163	CcSEcCtD
Levothyroxine—Confusional state—Etoposide—lung cancer	0.000159	0.00162	CcSEcCtD
Levothyroxine—Cardiac arrest—Doxorubicin—lung cancer	0.000159	0.00162	CcSEcCtD
Levothyroxine—Nausea—Erlotinib—lung cancer	0.000158	0.00161	CcSEcCtD
Levothyroxine—Mood swings—Doxorubicin—lung cancer	0.000158	0.00161	CcSEcCtD
Levothyroxine—ABCB1—lung—lung cancer	0.000158	0.0038	CbGeAlD
Levothyroxine—Diarrhoea—Vinorelbine—lung cancer	0.000158	0.00161	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000157	0.0016	CcSEcCtD
Levothyroxine—Feeling abnormal—Irinotecan—lung cancer	0.000157	0.00159	CcSEcCtD
Levothyroxine—Confusional state—Paclitaxel—lung cancer	0.000156	0.00159	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Irinotecan—lung cancer	0.000155	0.00158	CcSEcCtD
Levothyroxine—Dehydration—Doxorubicin—lung cancer	0.000155	0.00158	CcSEcCtD
Levothyroxine—Tachycardia—Etoposide—lung cancer	0.000154	0.00157	CcSEcCtD
Levothyroxine—Dyspnoea—Cisplatin—lung cancer	0.000154	0.00157	CcSEcCtD
Levothyroxine—Hyperhidrosis—Etoposide—lung cancer	0.000153	0.00156	CcSEcCtD
Levothyroxine—Feeling abnormal—Gemcitabine—lung cancer	0.000153	0.00155	CcSEcCtD
Levothyroxine—Shock—Paclitaxel—lung cancer	0.000153	0.00155	CcSEcCtD
Levothyroxine—Tachycardia—Paclitaxel—lung cancer	0.000151	0.00154	CcSEcCtD
Levothyroxine—Abdominal pain—Irinotecan—lung cancer	0.00015	0.00153	CcSEcCtD
Levothyroxine—Body temperature increased—Irinotecan—lung cancer	0.00015	0.00153	CcSEcCtD
Levothyroxine—Hyperhidrosis—Paclitaxel—lung cancer	0.00015	0.00153	CcSEcCtD
Levothyroxine—Muscular weakness—Doxorubicin—lung cancer	0.000147	0.0015	CcSEcCtD
Levothyroxine—Vomiting—Vinorelbine—lung cancer	0.000147	0.00149	CcSEcCtD
Levothyroxine—Body temperature increased—Gemcitabine—lung cancer	0.000146	0.00149	CcSEcCtD
Levothyroxine—Rash—Vinorelbine—lung cancer	0.000145	0.00148	CcSEcCtD
Levothyroxine—Dermatitis—Vinorelbine—lung cancer	0.000145	0.00148	CcSEcCtD
Levothyroxine—Headache—Vinorelbine—lung cancer	0.000144	0.00147	CcSEcCtD
Levothyroxine—Dysphagia—Doxorubicin—lung cancer	0.000144	0.00147	CcSEcCtD
Levothyroxine—Sweating—Methotrexate—lung cancer	0.000142	0.00145	CcSEcCtD
Levothyroxine—Palpitations—Docetaxel—lung cancer	0.000142	0.00145	CcSEcCtD
Levothyroxine—Feeling abnormal—Cisplatin—lung cancer	0.000142	0.00145	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000141	0.00144	CcSEcCtD
Levothyroxine—Dyspnoea—Etoposide—lung cancer	0.000141	0.00144	CcSEcCtD
Levothyroxine—Angina pectoris—Doxorubicin—lung cancer	0.000141	0.00143	CcSEcCtD
Levothyroxine—Insomnia—Paclitaxel—lung cancer	0.00014	0.00143	CcSEcCtD
Levothyroxine—Convulsion—Docetaxel—lung cancer	0.00014	0.00142	CcSEcCtD
Levothyroxine—Dyspnoea—Paclitaxel—lung cancer	0.000138	0.00141	CcSEcCtD
Levothyroxine—Arthralgia—Docetaxel—lung cancer	0.000137	0.0014	CcSEcCtD
Levothyroxine—Nausea—Vinorelbine—lung cancer	0.000137	0.00139	CcSEcCtD
Levothyroxine—Body temperature increased—Cisplatin—lung cancer	0.000136	0.00139	CcSEcCtD
Levothyroxine—Asthenia—Irinotecan—lung cancer	0.000136	0.00139	CcSEcCtD
Levothyroxine—Fatigue—Etoposide—lung cancer	0.000136	0.00139	CcSEcCtD
Levothyroxine—Fatigue—Paclitaxel—lung cancer	0.000134	0.00136	CcSEcCtD
Levothyroxine—Asthenia—Gemcitabine—lung cancer	0.000133	0.00135	CcSEcCtD
Levothyroxine—Confusional state—Docetaxel—lung cancer	0.000133	0.00135	CcSEcCtD
Levothyroxine—Pruritus—Gemcitabine—lung cancer	0.000131	0.00133	CcSEcCtD
Levothyroxine—Weight decreased—Doxorubicin—lung cancer	0.00013	0.00133	CcSEcCtD
Levothyroxine—Feeling abnormal—Etoposide—lung cancer	0.00013	0.00133	CcSEcCtD
Levothyroxine—Diarrhoea—Irinotecan—lung cancer	0.00013	0.00132	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Etoposide—lung cancer	0.000129	0.00132	CcSEcCtD
Levothyroxine—Shock—Docetaxel—lung cancer	0.000129	0.00132	CcSEcCtD
Levothyroxine—Tachycardia—Docetaxel—lung cancer	0.000128	0.00131	CcSEcCtD
Levothyroxine—Feeling abnormal—Paclitaxel—lung cancer	0.000128	0.0013	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Paclitaxel—lung cancer	0.000127	0.00129	CcSEcCtD
Levothyroxine—Diarrhoea—Gemcitabine—lung cancer	0.000127	0.00129	CcSEcCtD
Levothyroxine—Urticaria—Etoposide—lung cancer	0.000126	0.00128	CcSEcCtD
Levothyroxine—Abdominal pain—Etoposide—lung cancer	0.000125	0.00127	CcSEcCtD
Levothyroxine—Body temperature increased—Etoposide—lung cancer	0.000125	0.00127	CcSEcCtD
Levothyroxine—Asthenia—Cisplatin—lung cancer	0.000124	0.00126	CcSEcCtD
Levothyroxine—Sweating—Doxorubicin—lung cancer	0.000123	0.00126	CcSEcCtD
Levothyroxine—Urticaria—Paclitaxel—lung cancer	0.000123	0.00125	CcSEcCtD
Levothyroxine—Abdominal pain—Paclitaxel—lung cancer	0.000123	0.00125	CcSEcCtD
Levothyroxine—Body temperature increased—Paclitaxel—lung cancer	0.000123	0.00125	CcSEcCtD
Levothyroxine—Vomiting—Irinotecan—lung cancer	0.000121	0.00123	CcSEcCtD
Levothyroxine—Rash—Irinotecan—lung cancer	0.00012	0.00122	CcSEcCtD
Levothyroxine—Dermatitis—Irinotecan—lung cancer	0.00012	0.00122	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Docetaxel—lung cancer	0.00012	0.00122	CcSEcCtD
Levothyroxine—Headache—Irinotecan—lung cancer	0.000119	0.00121	CcSEcCtD
Levothyroxine—Insomnia—Docetaxel—lung cancer	0.000119	0.00121	CcSEcCtD
Levothyroxine—Diarrhoea—Cisplatin—lung cancer	0.000118	0.0012	CcSEcCtD
Levothyroxine—Alopecia—Methotrexate—lung cancer	0.000118	0.0012	CcSEcCtD
Levothyroxine—Vomiting—Gemcitabine—lung cancer	0.000118	0.0012	CcSEcCtD
Levothyroxine—Dyspnoea—Docetaxel—lung cancer	0.000117	0.00119	CcSEcCtD
Levothyroxine—Rash—Gemcitabine—lung cancer	0.000117	0.00119	CcSEcCtD
Levothyroxine—Dermatitis—Gemcitabine—lung cancer	0.000117	0.00119	CcSEcCtD
Levothyroxine—Headache—Gemcitabine—lung cancer	0.000116	0.00118	CcSEcCtD
Levothyroxine—Asthenia—Etoposide—lung cancer	0.000113	0.00116	CcSEcCtD
Levothyroxine—Fatigue—Docetaxel—lung cancer	0.000113	0.00115	CcSEcCtD
Levothyroxine—Nausea—Irinotecan—lung cancer	0.000113	0.00115	CcSEcCtD
Levothyroxine—Pruritus—Etoposide—lung cancer	0.000112	0.00114	CcSEcCtD
Levothyroxine—Asthenia—Paclitaxel—lung cancer	0.000111	0.00113	CcSEcCtD
Levothyroxine—Nausea—Gemcitabine—lung cancer	0.00011	0.00112	CcSEcCtD
Levothyroxine—Vomiting—Cisplatin—lung cancer	0.00011	0.00112	CcSEcCtD
Levothyroxine—Pruritus—Paclitaxel—lung cancer	0.00011	0.00112	CcSEcCtD
Levothyroxine—Rash—Cisplatin—lung cancer	0.000109	0.00111	CcSEcCtD
Levothyroxine—Dermatitis—Cisplatin—lung cancer	0.000109	0.00111	CcSEcCtD
Levothyroxine—Feeling abnormal—Docetaxel—lung cancer	0.000108	0.0011	CcSEcCtD
Levothyroxine—Diarrhoea—Etoposide—lung cancer	0.000108	0.0011	CcSEcCtD
Levothyroxine—ABCB1—lymph node—lung cancer	0.000108	0.0026	CbGeAlD
Levothyroxine—Gastrointestinal pain—Docetaxel—lung cancer	0.000107	0.00109	CcSEcCtD
Levothyroxine—Flushing—Doxorubicin—lung cancer	0.000107	0.00109	CcSEcCtD
Levothyroxine—Diarrhoea—Paclitaxel—lung cancer	0.000106	0.00108	CcSEcCtD
Levothyroxine—Body temperature increased—Docetaxel—lung cancer	0.000104	0.00106	CcSEcCtD
Levothyroxine—Abdominal pain—Docetaxel—lung cancer	0.000104	0.00106	CcSEcCtD
Levothyroxine—Arrhythmia—Doxorubicin—lung cancer	0.000103	0.00105	CcSEcCtD
Levothyroxine—Nausea—Cisplatin—lung cancer	0.000103	0.00104	CcSEcCtD
Levothyroxine—Alopecia—Doxorubicin—lung cancer	0.000102	0.00104	CcSEcCtD
Levothyroxine—Convulsion—Methotrexate—lung cancer	0.000101	0.00102	CcSEcCtD
Levothyroxine—Vomiting—Etoposide—lung cancer	0.000101	0.00102	CcSEcCtD
Levothyroxine—Rash—Etoposide—lung cancer	9.97e-05	0.00102	CcSEcCtD
Levothyroxine—Dermatitis—Etoposide—lung cancer	9.96e-05	0.00101	CcSEcCtD
Levothyroxine—Headache—Etoposide—lung cancer	9.91e-05	0.00101	CcSEcCtD
Levothyroxine—Arthralgia—Methotrexate—lung cancer	9.88e-05	0.00101	CcSEcCtD
Levothyroxine—Tension—Doxorubicin—lung cancer	9.86e-05	0.001	CcSEcCtD
Levothyroxine—Vomiting—Paclitaxel—lung cancer	9.86e-05	0.001	CcSEcCtD
Levothyroxine—Rash—Paclitaxel—lung cancer	9.78e-05	0.000995	CcSEcCtD
Levothyroxine—Dermatitis—Paclitaxel—lung cancer	9.77e-05	0.000994	CcSEcCtD
Levothyroxine—Nervousness—Doxorubicin—lung cancer	9.76e-05	0.000994	CcSEcCtD
Levothyroxine—Headache—Paclitaxel—lung cancer	9.71e-05	0.000989	CcSEcCtD
Levothyroxine—Confusional state—Methotrexate—lung cancer	9.55e-05	0.000972	CcSEcCtD
Levothyroxine—Asthenia—Docetaxel—lung cancer	9.43e-05	0.00096	CcSEcCtD
Levothyroxine—Nausea—Etoposide—lung cancer	9.39e-05	0.000956	CcSEcCtD
Levothyroxine—Pruritus—Docetaxel—lung cancer	9.3e-05	0.000947	CcSEcCtD
Levothyroxine—Agitation—Doxorubicin—lung cancer	9.24e-05	0.00094	CcSEcCtD
Levothyroxine—Nausea—Paclitaxel—lung cancer	9.21e-05	0.000938	CcSEcCtD
Levothyroxine—Hyperhidrosis—Methotrexate—lung cancer	9.16e-05	0.000932	CcSEcCtD
Levothyroxine—Diarrhoea—Docetaxel—lung cancer	8.99e-05	0.000915	CcSEcCtD
Levothyroxine—Palpitations—Doxorubicin—lung cancer	8.88e-05	0.000904	CcSEcCtD
Levothyroxine—Convulsion—Doxorubicin—lung cancer	8.71e-05	0.000886	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Methotrexate—lung cancer	8.63e-05	0.000879	CcSEcCtD
Levothyroxine—Insomnia—Methotrexate—lung cancer	8.57e-05	0.000872	CcSEcCtD
Levothyroxine—Arthralgia—Doxorubicin—lung cancer	8.56e-05	0.000871	CcSEcCtD
Levothyroxine—Anxiety—Doxorubicin—lung cancer	8.53e-05	0.000868	CcSEcCtD
Levothyroxine—Dyspnoea—Methotrexate—lung cancer	8.44e-05	0.00086	CcSEcCtD
Levothyroxine—Vomiting—Docetaxel—lung cancer	8.36e-05	0.000851	CcSEcCtD
Levothyroxine—Rash—Docetaxel—lung cancer	8.29e-05	0.000844	CcSEcCtD
Levothyroxine—Dermatitis—Docetaxel—lung cancer	8.28e-05	0.000843	CcSEcCtD
Levothyroxine—Confusional state—Doxorubicin—lung cancer	8.27e-05	0.000842	CcSEcCtD
Levothyroxine—Headache—Docetaxel—lung cancer	8.23e-05	0.000838	CcSEcCtD
Levothyroxine—Fatigue—Methotrexate—lung cancer	8.17e-05	0.000831	CcSEcCtD
Levothyroxine—Shock—Doxorubicin—lung cancer	8.07e-05	0.000822	CcSEcCtD
Levothyroxine—Tachycardia—Doxorubicin—lung cancer	8.01e-05	0.000815	CcSEcCtD
Levothyroxine—Hyperhidrosis—Doxorubicin—lung cancer	7.93e-05	0.000807	CcSEcCtD
Levothyroxine—Nausea—Docetaxel—lung cancer	7.81e-05	0.000795	CcSEcCtD
Levothyroxine—Feeling abnormal—Methotrexate—lung cancer	7.81e-05	0.000795	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Methotrexate—lung cancer	7.75e-05	0.000789	CcSEcCtD
Levothyroxine—Urticaria—Methotrexate—lung cancer	7.53e-05	0.000766	CcSEcCtD
Levothyroxine—Abdominal pain—Methotrexate—lung cancer	7.49e-05	0.000762	CcSEcCtD
Levothyroxine—Body temperature increased—Methotrexate—lung cancer	7.49e-05	0.000762	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Doxorubicin—lung cancer	7.47e-05	0.000761	CcSEcCtD
Levothyroxine—Insomnia—Doxorubicin—lung cancer	7.42e-05	0.000755	CcSEcCtD
Levothyroxine—Dyspnoea—Doxorubicin—lung cancer	7.31e-05	0.000744	CcSEcCtD
Levothyroxine—Fatigue—Doxorubicin—lung cancer	7.07e-05	0.00072	CcSEcCtD
Levothyroxine—Asthenia—Methotrexate—lung cancer	6.8e-05	0.000692	CcSEcCtD
Levothyroxine—Feeling abnormal—Doxorubicin—lung cancer	6.76e-05	0.000688	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Doxorubicin—lung cancer	6.71e-05	0.000683	CcSEcCtD
Levothyroxine—Pruritus—Methotrexate—lung cancer	6.7e-05	0.000682	CcSEcCtD
Levothyroxine—Urticaria—Doxorubicin—lung cancer	6.52e-05	0.000663	CcSEcCtD
Levothyroxine—Abdominal pain—Doxorubicin—lung cancer	6.48e-05	0.00066	CcSEcCtD
Levothyroxine—Body temperature increased—Doxorubicin—lung cancer	6.48e-05	0.00066	CcSEcCtD
Levothyroxine—Diarrhoea—Methotrexate—lung cancer	6.48e-05	0.00066	CcSEcCtD
Levothyroxine—Vomiting—Methotrexate—lung cancer	6.02e-05	0.000613	CcSEcCtD
Levothyroxine—Rash—Methotrexate—lung cancer	5.97e-05	0.000608	CcSEcCtD
Levothyroxine—Dermatitis—Methotrexate—lung cancer	5.97e-05	0.000607	CcSEcCtD
Levothyroxine—Headache—Methotrexate—lung cancer	5.93e-05	0.000604	CcSEcCtD
Levothyroxine—Asthenia—Doxorubicin—lung cancer	5.88e-05	0.000599	CcSEcCtD
Levothyroxine—Pruritus—Doxorubicin—lung cancer	5.8e-05	0.000591	CcSEcCtD
Levothyroxine—Nausea—Methotrexate—lung cancer	5.63e-05	0.000573	CcSEcCtD
Levothyroxine—Diarrhoea—Doxorubicin—lung cancer	5.61e-05	0.000571	CcSEcCtD
Levothyroxine—Vomiting—Doxorubicin—lung cancer	5.22e-05	0.000531	CcSEcCtD
Levothyroxine—Rash—Doxorubicin—lung cancer	5.17e-05	0.000526	CcSEcCtD
Levothyroxine—Dermatitis—Doxorubicin—lung cancer	5.17e-05	0.000526	CcSEcCtD
Levothyroxine—Headache—Doxorubicin—lung cancer	5.14e-05	0.000523	CcSEcCtD
Levothyroxine—Nausea—Doxorubicin—lung cancer	4.87e-05	0.000496	CcSEcCtD
Levothyroxine—TTR—Signaling Pathways—MMP9—lung cancer	7.67e-06	7.63e-05	CbGpPWpGaD
Levothyroxine—ALB—Transmembrane transport of small molecules—APOA1—lung cancer	7.65e-06	7.62e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CDKN1A—lung cancer	7.64e-06	7.61e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—PTEN—lung cancer	7.62e-06	7.59e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—AKR1C1—lung cancer	7.57e-06	7.54e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—NCOA3—lung cancer	7.52e-06	7.49e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PIK3CD—lung cancer	7.5e-06	7.46e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—CREBBP—lung cancer	7.49e-06	7.45e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—NCOA3—lung cancer	7.48e-06	7.44e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CKB—lung cancer	7.48e-06	7.44e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—ALB—lung cancer	7.4e-06	7.37e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	7.39e-06	7.36e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—UGT1A1—lung cancer	7.35e-06	7.32e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	7.35e-06	7.32e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—APOA1—lung cancer	7.34e-06	7.3e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ADCY1—lung cancer	7.32e-06	7.28e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ABCG2—lung cancer	7.32e-06	7.28e-05	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—PIK3CA—lung cancer	7.32e-06	7.28e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—CYP1A1—lung cancer	7.31e-06	7.28e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—ABCG2—lung cancer	7.28e-06	7.24e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—ADCY1—lung cancer	7.28e-06	7.24e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—EP300—lung cancer	7.27e-06	7.24e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—ERCC2—lung cancer	7.25e-06	7.22e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	7.2e-06	7.17e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—HPGDS—lung cancer	7.18e-06	7.14e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ENO2—lung cancer	7.18e-06	7.14e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—HPGDS—lung cancer	7.14e-06	7.1e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—ENO2—lung cancer	7.14e-06	7.1e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PPP2R1B—lung cancer	7.13e-06	7.1e-05	CbGpPWpGaD
Levothyroxine—TTR—Disease—HRAS—lung cancer	7.11e-06	7.07e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—PIK3CD—lung cancer	7.1e-06	7.06e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PPP2R1B—lung cancer	7.09e-06	7.06e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—GNG11—lung cancer	7.09e-06	7.06e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—SRC—lung cancer	7.07e-06	7.04e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—lung cancer	7.04e-06	7e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GSTM2—lung cancer	7.03e-06	7e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CNDP2—lung cancer	7.03e-06	7e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	7.03e-06	6.99e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—POMC—lung cancer	7e-06	6.96e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	6.97e-06	6.94e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—GSTT1—lung cancer	6.96e-06	6.93e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—GSTT1—lung cancer	6.92e-06	6.89e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—VEGFA—lung cancer	6.89e-06	6.85e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—GCLC—lung cancer	6.88e-06	6.85e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CYP2A6—lung cancer	6.88e-06	6.85e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	6.85e-06	6.82e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—GCLC—lung cancer	6.84e-06	6.81e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CYP2A6—lung cancer	6.84e-06	6.81e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—MTMR3—lung cancer	6.84e-06	6.81e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—STAT3—lung cancer	6.82e-06	6.79e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	6.81e-06	6.78e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—NRAS—lung cancer	6.8e-06	6.77e-05	CbGpPWpGaD
Levothyroxine—TTR—Disease—IL6—lung cancer	6.8e-06	6.77e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ALDOA—lung cancer	6.75e-06	6.72e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	6.71e-06	6.68e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PIK3CG—lung cancer	6.7e-06	6.67e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PGAM1—lung cancer	6.66e-06	6.63e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—NCOA3—lung cancer	6.55e-06	6.52e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PIK3CB—lung cancer	6.53e-06	6.5e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ENO1—lung cancer	6.52e-06	6.49e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—MAPK3—lung cancer	6.51e-06	6.48e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	6.5e-06	6.47e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—ENO1—lung cancer	6.48e-06	6.45e-05	CbGpPWpGaD
Levothyroxine—ALB—Transmembrane transport of small molecules—CREBBP—lung cancer	6.48e-06	6.45e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PTGS2—lung cancer	6.47e-06	6.44e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	6.46e-06	6.43e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—lung cancer	6.41e-06	6.38e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—POMC—lung cancer	6.38e-06	6.35e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ABCG2—lung cancer	6.37e-06	6.35e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ADCY1—lung cancer	6.37e-06	6.35e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CYP2A7—lung cancer	6.36e-06	6.33e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—RAF1—lung cancer	6.34e-06	6.31e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—MYC—lung cancer	6.34e-06	6.31e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—APOA1—lung cancer	6.28e-06	6.25e-05	CbGpPWpGaD
Levothyroxine—TTR—Disease—AKT1—lung cancer	6.27e-06	6.24e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ENO2—lung cancer	6.25e-06	6.22e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—HPGDS—lung cancer	6.25e-06	6.22e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—SDC4—lung cancer	6.22e-06	6.19e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PPP2R1B—lung cancer	6.21e-06	6.18e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—CREBBP—lung cancer	6.21e-06	6.18e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—EGFR—lung cancer	6.2e-06	6.17e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—PIK3CB—lung cancer	6.19e-06	6.16e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—GSTT1—lung cancer	6.06e-06	6.04e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	6.01e-06	5.98e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CYP2A6—lung cancer	5.99e-06	5.97e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—GCLC—lung cancer	5.99e-06	5.97e-05	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—AKT1—lung cancer	5.98e-06	5.95e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PIK3CD—lung cancer	5.89e-06	5.86e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	5.88e-06	5.86e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—KRAS—lung cancer	5.85e-06	5.83e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CYP2E1—lung cancer	5.85e-06	5.82e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CYP2E1—lung cancer	5.82e-06	5.79e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—ALB—lung cancer	5.81e-06	5.79e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—NQO1—lung cancer	5.78e-06	5.76e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—NQO1—lung cancer	5.75e-06	5.72e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PIK3CG—lung cancer	5.73e-06	5.7e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ENO1—lung cancer	5.68e-06	5.66e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—IL2—lung cancer	5.68e-06	5.65e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	5.68e-06	5.65e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—RRM1—lung cancer	5.67e-06	5.64e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GSTA3—lung cancer	5.67e-06	5.64e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	5.66e-06	5.64e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PTEN—lung cancer	5.65e-06	5.62e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	5.63e-06	5.61e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	5.61e-06	5.59e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	5.58e-06	5.55e-05	CbGpPWpGaD
Levothyroxine—ALB—Transmembrane transport of small molecules—RAF1—lung cancer	5.48e-06	5.46e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—POMC—lung cancer	5.45e-06	5.43e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—EP300—lung cancer	5.38e-06	5.36e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—PIK3CA—lung cancer	5.38e-06	5.35e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—B4GALT5—lung cancer	5.33e-06	5.3e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	5.31e-06	5.29e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—CREBBP—lung cancer	5.31e-06	5.29e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—STK11—lung cancer	5.21e-06	5.19e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—TP53—lung cancer	5.2e-06	5.18e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—STK11—lung cancer	5.18e-06	5.16e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GSTA4—lung cancer	5.18e-06	5.16e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PIK3CB—lung cancer	5.13e-06	5.11e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—EP300—lung cancer	5.1e-06	5.07e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CYP2E1—lung cancer	5.1e-06	5.07e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PTGS2—lung cancer	5.09e-06	5.06e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GSTA2—lung cancer	5.05e-06	5.03e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—NQO1—lung cancer	5.04e-06	5.02e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PIK3CD—lung cancer	5.04e-06	5.01e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—HRAS—lung cancer	4.98e-06	4.95e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—ALB—lung cancer	4.97e-06	4.95e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—SRC—lung cancer	4.96e-06	4.93e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.89e-06	4.87e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GSTA1—lung cancer	4.87e-06	4.85e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.87e-06	4.84e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—VEGFA—lung cancer	4.83e-06	4.81e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—GSTP1—lung cancer	4.82e-06	4.8e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ABCC3—lung cancer	4.82e-06	4.8e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	4.81e-06	4.78e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—GSTP1—lung cancer	4.8e-06	4.77e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—NRAS—lung cancer	4.77e-06	4.75e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—IL6—lung cancer	4.76e-06	4.74e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CAT—lung cancer	4.69e-06	4.67e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CAT—lung cancer	4.67e-06	4.65e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—lung cancer	4.67e-06	4.65e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—AKR1C1—lung cancer	4.67e-06	4.64e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—EP300—lung cancer	4.64e-06	4.62e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—MAPK3—lung cancer	4.57e-06	4.55e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ABCB1—lung cancer	4.57e-06	4.55e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—STK11—lung cancer	4.54e-06	4.52e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—ABCB1—lung cancer	4.54e-06	4.52e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—UGT1A1—lung cancer	4.53e-06	4.51e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—TYMS—lung cancer	4.49e-06	4.46e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—TYMS—lung cancer	4.46e-06	4.44e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PTEN—lung cancer	4.44e-06	4.41e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—GSTM1—lung cancer	4.43e-06	4.41e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—GSTM1—lung cancer	4.41e-06	4.39e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—AKT1—lung cancer	4.39e-06	4.37e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PIK3CB—lung cancer	4.39e-06	4.37e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GNG11—lung cancer	4.37e-06	4.35e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PTGS2—lung cancer	4.35e-06	4.33e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—EP300—lung cancer	4.23e-06	4.21e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—GSTP1—lung cancer	4.2e-06	4.18e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CYP1A1—lung cancer	4.2e-06	4.18e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CYP1A1—lung cancer	4.18e-06	4.16e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ERCC2—lung cancer	4.17e-06	4.15e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ALDOA—lung cancer	4.16e-06	4.14e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—ERCC2—lung cancer	4.14e-06	4.13e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—KRAS—lung cancer	4.1e-06	4.09e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CAT—lung cancer	4.09e-06	4.07e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—NCOA3—lung cancer	4.04e-06	4.02e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PIK3CA—lung cancer	3.98e-06	3.96e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ABCG2—lung cancer	3.93e-06	3.91e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ADCY1—lung cancer	3.93e-06	3.91e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—TYMS—lung cancer	3.91e-06	3.89e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—GSTM1—lung cancer	3.86e-06	3.84e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—HPGDS—lung cancer	3.85e-06	3.83e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ENO2—lung cancer	3.85e-06	3.83e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PPP2R1B—lung cancer	3.83e-06	3.81e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PTEN—lung cancer	3.79e-06	3.78e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—PIK3CA—lung cancer	3.77e-06	3.75e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GSTT1—lung cancer	3.74e-06	3.72e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CYP2A6—lung cancer	3.69e-06	3.68e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GCLC—lung cancer	3.69e-06	3.68e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CYP1A1—lung cancer	3.66e-06	3.64e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—TP53—lung cancer	3.65e-06	3.63e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ERCC2—lung cancer	3.63e-06	3.61e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—EP300—lung cancer	3.62e-06	3.6e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—APOA1—lung cancer	3.61e-06	3.59e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—APOA1—lung cancer	3.59e-06	3.57e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ENO1—lung cancer	3.5e-06	3.48e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—HRAS—lung cancer	3.49e-06	3.47e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.45e-06	3.44e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.43e-06	3.42e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PIK3CG—lung cancer	3.29e-06	3.28e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PIK3CG—lung cancer	3.27e-06	3.26e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—AKT1—lung cancer	3.25e-06	3.24e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—APOA1—lung cancer	3.14e-06	3.13e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CYP2E1—lung cancer	3.14e-06	3.13e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—POMC—lung cancer	3.13e-06	3.12e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PIK3CA—lung cancer	3.13e-06	3.11e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—POMC—lung cancer	3.12e-06	3.1e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—NQO1—lung cancer	3.1e-06	3.09e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—AKT1—lung cancer	3.08e-06	3.07e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CREBBP—lung cancer	3.05e-06	3.04e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CREBBP—lung cancer	3.03e-06	3.02e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PIK3CD—lung cancer	2.89e-06	2.88e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PIK3CD—lung cancer	2.88e-06	2.86e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PIK3CG—lung cancer	2.87e-06	2.85e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ALB—lung cancer	2.86e-06	2.84e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—STK11—lung cancer	2.8e-06	2.79e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—POMC—lung cancer	2.73e-06	2.72e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PIK3CA—lung cancer	2.68e-06	2.66e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CREBBP—lung cancer	2.66e-06	2.65e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GSTP1—lung cancer	2.59e-06	2.58e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—AKT1—lung cancer	2.56e-06	2.54e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PIK3CB—lung cancer	2.52e-06	2.51e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PIK3CD—lung cancer	2.52e-06	2.51e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CAT—lung cancer	2.52e-06	2.51e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PIK3CB—lung cancer	2.51e-06	2.5e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PTGS2—lung cancer	2.5e-06	2.49e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ALB—lung cancer	2.49e-06	2.48e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PTGS2—lung cancer	2.49e-06	2.47e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ABCB1—lung cancer	2.45e-06	2.44e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—TYMS—lung cancer	2.41e-06	2.4e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GSTM1—lung cancer	2.38e-06	2.37e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CYP1A1—lung cancer	2.26e-06	2.25e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ERCC2—lung cancer	2.24e-06	2.23e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PIK3CB—lung cancer	2.2e-06	2.19e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—AKT1—lung cancer	2.19e-06	2.18e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PTEN—lung cancer	2.18e-06	2.17e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PTGS2—lung cancer	2.18e-06	2.17e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PTEN—lung cancer	2.17e-06	2.16e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—EP300—lung cancer	2.08e-06	2.07e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—EP300—lung cancer	2.07e-06	2.06e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—APOA1—lung cancer	1.94e-06	1.93e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PTEN—lung cancer	1.9e-06	1.89e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—EP300—lung cancer	1.81e-06	1.8e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PIK3CG—lung cancer	1.77e-06	1.76e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—POMC—lung cancer	1.68e-06	1.67e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CREBBP—lung cancer	1.64e-06	1.63e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PIK3CD—lung cancer	1.55e-06	1.55e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PIK3CA—lung cancer	1.54e-06	1.53e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ALB—lung cancer	1.53e-06	1.53e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PIK3CA—lung cancer	1.53e-06	1.52e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PIK3CB—lung cancer	1.35e-06	1.35e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PTGS2—lung cancer	1.34e-06	1.34e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PIK3CA—lung cancer	1.34e-06	1.33e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—AKT1—lung cancer	1.26e-06	1.25e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—AKT1—lung cancer	1.25e-06	1.24e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PTEN—lung cancer	1.17e-06	1.16e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—EP300—lung cancer	1.12e-06	1.11e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—AKT1—lung cancer	1.09e-06	1.09e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PIK3CA—lung cancer	8.25e-07	8.21e-06	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—AKT1—lung cancer	6.74e-07	6.71e-06	CbGpPWpGaD
